The National Heart Program, a HUF 3.6 billion research project led by Semmelweis University that was started on December 1, 2016 ended on November 30, 2020. The program’s main goal was to contribute to the reduction of mortality caused by cardiovascular diseases, and as a result of the project, the comprehensive developments and research conducted over the past four years helped to achieve significant advances in the prevention and treatment of two major diseases significant to public health: ischemic heart disease and heart failure. Participants of the program included the Városmajor Heart and Vascular Center, the Department of Pharmacology and Pharmacotherapy, the Department of Biophysics and Radiation Biology, the Department of Genetics, Cell- and Immunobiology, as well as four Hungarian small and medium-sized businesses including Pharmahungary 2000 Ltd., a member of the Pharmahungary Group.

For more details see news on Semmelweis University website.